There are 2789 resources available
Q&A
Presenter: Nicolas Girard
Session: Are we ready to consider chemotherapy + checkpoint inhibitor as the preferred option in the neoadjuvant setting?
Resources:
Slides
Webcast
Introduction by the chair
Presenter: Nicolas Girard
Session: Are we ready to consider chemotherapy + checkpoint inhibitor as the preferred option in the neoadjuvant setting?
Resources:
Slides
Webcast
Yes
Presenter: Heather Wakelee
Session: Are we ready to consider chemotherapy + checkpoint inhibitor as the preferred option in the neoadjuvant setting?
Resources:
Slides
Webcast
No
Presenter: Martin Reck
Session: Are we ready to consider chemotherapy + checkpoint inhibitor as the preferred option in the neoadjuvant setting?
Resources:
Slides
Webcast
Welcome and Opening remarks
Presenter: Giuseppe Curigliano
Session: ESMO Guidelines
Resources:
Slides
Webcast
Presentation of case 1: Patient with metastatic breast cancer
Presenter: Dario Trapani
Session: ESMO Guidelines
Resources:
Slides
Webcast
Discussion of case 1: Patient with metastatic breast cancer
Presenter: Peter Schmid
Session: ESMO Guidelines
Resources:
Slides
Webcast
Live Q&A
Presenter: Giuseppe Curigliano
Session: ESMO Guidelines
Resources:
Slides
Webcast
Presentation of case 2: Patient with early, resected EGFR-mutated NSCLC and subsequent relapse
Presenter: Alfredo Addeo
Session: ESMO Guidelines
Resources:
Slides
Webcast
Discussion of case 2: Patient with early, resected EGFR-mutated NSCLC and subsequent relapse
Presenter: Enriqueta Felip
Session: ESMO Guidelines
Resources:
Slides
Webcast